Your Messages Inbox
Your Article Summary
See Latest ArticlesAvalon Portfolio Nominates Slate of Directors for TomoTherapy Board
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/31/08
Avalon Portfolio, LLC, the investment arm of Avalon Capital Group, announced that it nominated four new directors to serve on the board of TomoTherapy Inc. This step is the latest move by the investment firm to generate greater value for the company's shareholders in the wake of the precipitous fall in TomoTherapy's stock price since 2007. The company has lost some 85% of its value year-to-date, with most of the decline occurring prior to the meltdown of the financial markets this fall. Avalon's nominees are committed to having the company's board explore all strategic options to maximize shareholder value.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Astellas hires new vice president of compliance
Astellas, 09/11/09
Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
Myriad, 09/22/09
Sanofi-aventis announces changes to Executive Committee
Sanofi-aventis, 11/04/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Article Search
Sponsor